Your browser doesn't support javascript.
loading
Correction: Genomic profiling reveals spatial intra-tumor heterogeneity in follicular lymphoma.
Araf, Shamzah; Wang, Jun; Korfi, Koorosh; Pangault, Celine; Kotsiou, Eleni; Rio-Machin, Ana; Rahim, Tahrima; Heward, James; Clear, Andrew; Iqbal, Sameena; Davies, Jeff K; Johnson, Peter; Calaminici, Maria; Montoto, Silvia; Auer, Rebecca; Chelala, Claude; Gribben, John G; Graham, Trevor A; Fest, Thierry; Fitzgibbon, Jude; Okosun, Jessica.
Afiliación
  • Araf S; Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK. s.araf@qmul.ac.uk.
  • Wang J; Centre for Genomic Health, Queen Mary University of London, London, UK. s.araf@qmul.ac.uk.
  • Korfi K; Centre for Molecular Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK.
  • Pangault C; Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK.
  • Kotsiou E; UMR INSERM 1236, Université de Rennes, 1, EFS de Bretagne, CHU de Rennes, Rennes, France.
  • Rio-Machin A; Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK.
  • Rahim T; Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK.
  • Heward J; Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK.
  • Clear A; Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK.
  • Iqbal S; Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK.
  • Davies JK; Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK.
  • Johnson P; Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK.
  • Calaminici M; Cancer Sciences Unit, Cancer Research UK Centre, Southampton, UK.
  • Montoto S; Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK.
  • Auer R; Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK.
  • Chelala C; Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK.
  • Gribben JG; Centre for Molecular Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK.
  • Graham TA; Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK.
  • Fest T; Evolution and Cancer Laboratory, Barts Cancer Institute, Queen Mary University of London, London, UK.
  • Fitzgibbon J; UMR INSERM 1236, Université de Rennes, 1, EFS de Bretagne, CHU de Rennes, Rennes, France.
  • Okosun J; Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK.
Leukemia ; 33(6): 1540, 2019 Jun.
Article en En | MEDLINE | ID: mdl-30903015
In the original version of this article the authors noted an omission in the author affiliations where the university details: Queen Mary University of London was not included in the original affiliation for the majority of the authors. The correct affiliations are as follows1. Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK3. Centre for Molecular Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK6. Evolution and Cancer Laboratory, Barts Cancer Institute, Queen Mary University of London, London, UK.

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Leukemia Asunto de la revista: HEMATOLOGIA / NEOPLASIAS Año: 2019 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Leukemia Asunto de la revista: HEMATOLOGIA / NEOPLASIAS Año: 2019 Tipo del documento: Article